Clinical Trials on Blepharospasm, Benign Essential

Total 2335 results

Hanmi Pharmaceutical Company Limited

Recruiting

A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients With Essential Hypertension (HM_APOLLO)

Hypertension

Korea, Republic of
Ceric Sàrl
Electroducer

Not yet recruiting

Feasibility Study Evaluating the Safety and Efficacy of the Renal Stimulation by Direct Wire Pacing, During Renal Denervation Procedure (RNS by DWP)

Essential Hypertension
Cairo University
STDF

Recruiting

Effect of DNS Exercises Training on Hypertension

Essential Hypertension

Egypt
Ahn-Gook Pharmaceuticals Co.,Ltd
Daehwa Pharmaceutical Co., Ltd.

Not yet recruiting

Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS

Essential Hypertension
Celltrion

Active, not recruiting

Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects

Essential Hypertension

Korea, Republic of
Organon and Co

Completed

BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333) (EASE)

Hypertension
Celltrion Pharm, Inc.

Completed

A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South Korea

Essential Hypertension

Korea, Republic of
University of Copenhagen
University of Aarhus

Completed

Repurposing Colchicine to Improve Vascular Function in Hypertension (RECTIFHY)

Essential Hypertension

Denmark
Idorsia Pharmaceuticals Ltd.

Completed

Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension

Essential Hypertension

United States, Canada, Israel, Puerto Rico
Dokuz Eylul University

Completed

The Effect of the Use of BATHE Interview Technique on Treatment Compliance in Hypertension Patients in Primary Care

Essential Hypertension

Turkey
Organon and Co

Terminated

An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325)

Hypertension
Organon and Co

Completed

Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)

Hypertension
Boryung Pharmaceutical Co., Ltd

Completed

BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination (FINAL)

Essential Hypertension

Korea, Republic of
Chinese University of Hong Kong

Completed

BRAVE Study With Uncontrolled Essential Hypertension (BRAVE Study) (BRAVE)

Hypertension

Hong Kong
Ahn-Gook Pharmaceuticals Co.,Ltd

Unknown

Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension

Hypertension
Novartis

Completed

Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension

Hypertension

Japan
Chengdu University of Traditional Chinese Medicine

Unknown

Tai Chi for Patients With Essential Hypertension

Hypertension

China
Universidad de Concepcion
Comisión Nacional de Investigación Científica y Tecnológica

Completed

Evaluation of a Transmedial Psychoeducational Program to Improve Pharmacological Adherence (AFAM)

Essential Hypertension

Chile
The Second Affiliated Hospital of Chongqing Medical...
Chongqing Medical University; Jiangsu Provincial People's Hospital; Zunyi Medical...

Unknown

Renal Sympathetic Modification in Patients With Essential Hypertension

Essential Hypertension

China
University Hospital Inselspital, Berne

Completed

RAS Peptide Profiles in Patients With Arterial Hypertension

Essential Hypertension

Switzerland
A.Menarini Asia-Pacific Holdings Pte Ltd

Completed

Observational Study of Efficacy and Safety of Nebivolol in Korean Patients With Essential Hypertension (BENEFIT)

Essential Hypertension

Korea, Republic of
Daiichi Sankyo Co., Ltd.

Completed

Study of CS-3150 in Patients With Essential Hypertension (ESAX-HTN)

Essential Hypertension

Japan
Merck Sharp & Dohme LLC

Completed

MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)

Hypertension
Novartis

Completed

Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.

Hypertension

Germany, United States
Novartis

Completed

Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.

Essential Hypertension

Switzerland, Germany
Novartis

Completed

Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension

Hypertension

Japan
Hanmi Pharmaceutical Company Limited

Completed

Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension

Hypertension

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets

Essential Hypertension

Korea, Republic of
Novartis Pharmaceuticals

Completed

Efficacy and Safety of LCZ696 Compared to Placebo in Patients With Essential Hypertension

Hypertension

China, Taiwan, Japan, Thailand, Korea, Republic of
Novartis Pharmaceuticals

Completed

A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension

Essential Hypertension

China, Taiwan, Japan, Thailand, Korea, Republic of
Novartis Pharmaceuticals

Completed

Efficacy and Safety of LCZ696A in Patients With Essential Hypertension

Hypertension

Spain, Italy, Netherlands, United States, Denmark, Taiwan, Argentina, Germany, Russian Federation, Slovakia, Canada, Hungary, Latvia, Lithuania, Poland, Finland, France, Sweden
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension

Essential Hypertension

China
Boryung Pharmaceutical Co., Ltd
Asan Medical Center; Chonnam National University Hospital; Seoul National University... and other collaborators

Completed

A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Essential Hypertension

Korea, Republic of
Daegu Catholic University Medical Center
The Korean Society of Ginseng

Completed

Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential Hypertension (KRGCBP)

Hypertension

Korea, Republic of
Abbott
Quintiles, Inc.; Synexus; author! et al. BV

Completed

Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension

Essential Hypertension

Germany, Russian Federation, United Kingdom
Boehringer Ingelheim

Completed

BIBR 277 Capsule in Patients With Essential Hypertension

Hypertension
Boehringer Ingelheim

Completed

Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension

Hypertension
PhaseBio Pharmaceuticals Inc.

Completed

Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension

Essential Hypertension

United States
Bayer

Completed

High Dose BAYA1040 CR: a Long Term Extension Study

Hypertension

Japan
Chong Kun Dang Pharmaceutical

Completed

Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension

Hypertension

Korea, Republic of
Novartis

Completed

Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine (AWESOME)

Essential Hypertension

Germany
Boehringer Ingelheim

Completed

3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension

Hypertension

Japan
Quantum Genomics SA

Completed

Phase I Study in Healthy Male Subjects Comparing QGC001 to Placebo

Essential Hypertension

France
Takeda

Completed

Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension

Hypertension

Poland, Germany, Bulgaria, Russian Federation, Serbia, Sweden, Netherlands, Estonia, Slovakia, Finland
University of Erlangen-Nürnberg Medical School

Completed

L-Arginine Metabolism in Essential Hypertension

Essential Hypertension

Germany
University of Athens

Unknown

Home Blood Pressure in Hypertension Management (HBP10)

Essential Hypertension

Greece
Boehringer Ingelheim

Completed

Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension

Hypertension
Takeda

Completed

Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension

Essential Hypertension

United States, Chile, Mexico
Fr Muller Homoeopathic Medical College
Rajiv Gandhi University of Health Sciences

Completed

Effectiveness of Viscum Album Mother Tincture as an Anti-hypertensive in Essential Hypertension

Hypertension

India
Takeda

Completed

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.

Essential Hypertension

United States, Canada

3

Subscribe